Home › Companies › Elevance Health, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Elevance Health, Inc.’s Form 8-K, filed May 13, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 13, 2026: 6 items on Elevance Health, Inc.’s Form 8-K, filed May 13, 2026: 3 elected · 2 approved · 1 not approved.
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Elevance Health, Inc. in the interactive database Compare manager voting policies
These tallies are Elevance Health, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 13, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Gail K. Boudreaux | 177,978,713 | 1,714,229 | 110,827 | -- | 14,637,570 | 99.0% | Elected | — |
| Elect Director: Robert L. Dixon, Jr. | 174,098,489 | 5,590,793 | 114,487 | -- | 14,637,570 | 97% | Elected | — |
| Elect Director: Deanna D. Strable | 175,331,822 | 4,360,980 | 110,967 | -- | 14,637,570 | 98% | Elected | — |
| 2. Advisory vote on the Company's executive compensation | 172,363,616 | 7,240,619 | 199,534 | -- | 14,637,570 | 96% | Approved | — |
| 3. Ratification of the appointment of Ernst & Young LLP | 175,183,332 | 19,141,697 | 116,310 | -- | -- | 90% | Approved | — |
| 4. Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups | 15,587,160 | 162,924,290 | 1,292,319 | -- | 14,637,570 | 9% | Not approved | — |
Source: Elevance Health, Inc., Form 8-K, filed with the SEC on May 13, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
1,158 asset managers disclosed a vote on at least one Elevance Health, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 9 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Gail K. Boudreaux
Elevance Health, Inc.’s own tally for this item (“Elect Director: Gail K. Boudreaux”): 177,978,713 for, 1,714,229 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2029 based on the following votes:”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 201 asset managers below reported 64,429,082 for, 20,522 against, 8,056 abstained, 169 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,030,838 | 23 | 1 | 0 | For |
| BlackRock | 7,240,625 | 0 | 0 | 0 | For |
| Fidelity | 5,246,575 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 3,019,702 | 0 | 0 | 0 | For |
| Invesco | 2,644,440 | 0 | 0 | 0 | For |
| State Street | 2,450,750 | 18 | 0 | 0 | For |
| T. Rowe Price | 2,029,476 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,987,902 | 0 | 0 | 0 | For |
| Charles Schwab | 1,734,521 | 0 | 0 | 0 | For |
| MFS | 1,568,797 | 0 | 0 | 0 | For |
| TIAA | 1,383,393 | 0 | 0 | 0 | For |
| Capital Group | 1,057,832 | 0 | 0 | 0 | For |
| John Hancock | 959,122 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 924,953 | 0 | 0 | 0 | For |
| Hartford | 812,552 | 0 | 0 | 0 | For |
| Dimensional | 790,471 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 700,704 | 0 | 0 | 0 | For |
| First Trust | 597,911 | 0 | 0 | 0 | For |
| GMO | 589,528 | 0 | 0 | 0 | For |
| BNY Mellon | 584,731 | 0 | 0 | 0 | For |
| SEQUOIA FUND INC | 532,467 | 0 | 0 | 0 | For |
| Jackson National | 516,800 | 0 | 0 | 0 | For |
| Brighthouse | 505,616 | 0 | 0 | 0 | For |
| Nuveen | 440,529 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 341,168 | 0 | 0 | 0 | For |
Showing the 25 largest of 201 asset managers. All 201 are in the interactive database (link above).
Combines 10 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Robert L. Dixon, Jr.
Elevance Health, Inc.’s own tally for this item (“Elect Director: Robert L. Dixon, Jr.”): 174,098,489 for, 5,590,793 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2029 based on the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 201 asset managers below reported 64,401,989 for, 47,615 against, 8,056 abstained, 169 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,030,782 | 79 | 1 | 0 | For |
| BlackRock | 7,240,625 | 0 | 0 | 0 | For |
| Fidelity | 5,246,575 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 3,019,702 | 0 | 0 | 0 | For |
| Invesco | 2,644,440 | 0 | 0 | 0 | For |
| State Street | 2,450,737 | 31 | 0 | 0 | For |
| T. Rowe Price | 2,029,476 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,987,902 | 0 | 0 | 0 | For |
| Charles Schwab | 1,734,521 | 0 | 0 | 0 | For |
| MFS | 1,568,797 | 0 | 0 | 0 | For |
| TIAA | 1,383,393 | 0 | 0 | 0 | For |
| Capital Group | 1,057,832 | 0 | 0 | 0 | For |
| John Hancock | 959,122 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 924,953 | 0 | 0 | 0 | For |
| Hartford | 812,552 | 0 | 0 | 0 | For |
| Dimensional | 790,471 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 700,704 | 0 | 0 | 0 | For |
| First Trust | 597,911 | 0 | 0 | 0 | For |
| GMO | 589,528 | 0 | 0 | 0 | For |
| BNY Mellon | 584,731 | 0 | 0 | 0 | For |
| SEQUOIA FUND INC | 532,467 | 0 | 0 | 0 | For |
| Jackson National | 516,800 | 0 | 0 | 0 | For |
| Brighthouse | 505,616 | 0 | 0 | 0 | For |
| Nuveen | 440,529 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 341,168 | 0 | 0 | 0 | For |
Showing the 25 largest of 201 asset managers. All 201 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Deanna D. Strable
Elevance Health, Inc.’s own tally for this item (“Elect Director: Deanna D. Strable”): 175,331,822 for, 4,360,980 against, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees for director were elected to serve three-year terms to expire at the Company's annual meeting of shareholders in 2029 based on the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 199 asset managers below reported 64,334,918 for, 42,860 against, 8,056 abstained, 169 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,030,799 | 61 | 1 | 0 | For |
| BlackRock | 7,240,625 | 0 | 0 | 0 | For |
| Fidelity | 5,246,575 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 3,019,702 | 0 | 0 | 0 | For |
| Invesco | 2,644,440 | 0 | 0 | 0 | For |
| State Street | 2,450,768 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,029,476 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,987,902 | 0 | 0 | 0 | For |
| Charles Schwab | 1,734,521 | 0 | 0 | 0 | For |
| MFS | 1,568,797 | 0 | 0 | 0 | For |
| TIAA | 1,383,393 | 0 | 0 | 0 | For |
| Capital Group | 1,057,832 | 0 | 0 | 0 | For |
| John Hancock | 959,122 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 924,953 | 0 | 0 | 0 | For |
| Hartford | 812,358 | 194 | 0 | 0 | For |
| Dimensional | 790,471 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 700,704 | 0 | 0 | 0 | For |
| First Trust | 597,911 | 0 | 0 | 0 | For |
| GMO | 589,528 | 0 | 0 | 0 | For |
| BNY Mellon | 584,731 | 0 | 0 | 0 | For |
| SEQUOIA FUND INC | 532,467 | 0 | 0 | 0 | For |
| Jackson National | 516,800 | 0 | 0 | 0 | For |
| Brighthouse | 505,149 | 467 | 0 | 0 | For |
| Nuveen | 440,529 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 341,168 | 0 | 0 | 0 | For |
Showing the 25 largest of 199 asset managers. All 199 are in the interactive database (link above).
Combines 39 wordings of this item as funds reported it.
96% Approved · of votes cast
Prior year: 91.8% for (May 14, 2025 meeting) ▲ 4.2 pts
Description as filed by funds: Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay").
Elevance Health, Inc.’s own tally for this item (“2. Advisory vote on the Company's executive compensation”): 172,363,616 for, 7,240,619 against — passed, per its Form 8-K filed May 13, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The advisory vote on the compensation of the Company's named executive officers was approved based upon the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Elevance Health, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Compensation” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,030,771 | 89 | 2 | 0 | For |
| BlackRock | 7,240,625 | 0 | 0 | 0 | For |
| Fidelity | 5,246,575 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 3,019,702 | 0 | 0 | 0 | For |
| Invesco | 2,644,440 | 0 | 0 | 0 | For |
| State Street | 2,450,768 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,029,476 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,987,902 | 0 | 0 | 0 | For |
| Charles Schwab | 1,734,521 | 0 | 0 | 0 | For |
| MFS | 1,568,797 | 0 | 0 | 0 | For |
| TIAA | 1,383,393 | 0 | 0 | 0 | For |
| Capital Group | 1,057,832 | 0 | 0 | 0 | For |
| John Hancock | 959,122 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 924,953 | 0 | 0 | 0 | For |
| Hartford | 812,358 | 194 | 0 | 0 | For |
| Dimensional | 790,471 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 700,704 | 0 | 0 | 0 | For |
| First Trust | 597,911 | 0 | 0 | 0 | For |
| GMO | 589,528 | 0 | 0 | 0 | For |
| BNY Mellon | 584,731 | 0 | 0 | 0 | For |
| SEQUOIA FUND INC | 532,467 | 0 | 0 | 0 | For |
| Jackson National | 516,117 | 683 | 0 | 0 | For |
| Brighthouse | 505,149 | 467 | 0 | 0 | For |
| Nuveen | 440,529 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 341,168 | 0 | 0 | 0 | For |
Fund voting reports, all 194 managers: 64,259,138 for, 306,371 against, 8,057 abstained, 170 not voted, 40 mixed. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 9,885,019 | 6,675 | 0 | 0 | For |
| Wellington | 7,796,686 | 0 | 0 | 0 | For |
| State Street | 6,566,480 | 5,722 | 0 | 0 | For |
| T. Rowe Price | 5,313,754 | 5,217 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 5,203,975 | 0 | 0 | 0 | For |
| Invesco | 4,521,341 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES L P | 4,336,125 | 0 | 0 | 0 | For |
| Artisan | 4,219,629 | 0 | 0 | 0 | For |
| First Eagle Investment Management, LLC | 3,754,436 | 0 | 0 | 0 | For |
| Sanders Capital, LLC | 3,111,910 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2,649,997 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,039,083 | 0 | 0 | 0 | For |
| John Hancock | 1,959,719 | 0 | 0 | 0 | For |
| Nuveen | 1,958,557 | 0 | 0 | 0 | For |
| Northern Trust | 1,908,905 | 0 | 0 | 0 | For |
| Charles Schwab | 1,773,873 | 0 | 0 | 0 | For |
| Grantham, Mayo, Van Otterloo & Co. LLC | 1,734,738 | 0 | 0 | 0 | For |
| Amundi | 1,615,714 | 4,061 | 0 | 0 | For |
| UBS | 1,487,688 | 0 | 0 | 0 | For |
| Ruane, Cunniff & Goldfarb L.P. | 1,393,900 | 0 | 0 | 0 | For |
| Fidelity | 1,367,760 | 0 | 0 | 0 | For |
| Baupost | 1,275,154 | 0 | 0 | 0 | For |
| EAGLE CAPITAL MANAGEMENT LLC | 1,237,384 | 0 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 1,139,254 | 0 | 0 | 0 | For |
| Brave Warrior Advisors, LLC | 1,128,987 | 0 | 0 | 0 | For |
Institutional-manager reports, all 996 managers: 117,583,892 for, 4,499,275 against, 21,153 abstained, 94,906 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
90% Approved · of votes cast
Description as filed by funds: Ratification of Ernst & Young LLP as Auditors for 2026.
Elevance Health, Inc.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP”): 175,183,332 for, 19,141,697 against — passed, per its Form 8-K filed May 13, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified based upon the following votes:”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Elevance Health, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (6 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 198 asset managers below reported 62,613,765 for, 1,763,912 against, 8,056 abstained, 169 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 19,178,084 | 852,776 | 1 | 0 | For |
| BlackRock | 7,239,348 | 1,277 | 0 | 0 | For |
| Fidelity | 5,246,575 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 3,019,702 | 0 | 0 | 0 | For |
| Invesco | 2,644,440 | 0 | 0 | 0 | For |
| State Street | 2,450,737 | 31 | 0 | 0 | For |
| T. Rowe Price | 2,029,476 | 0 | 0 | 0 | For |
| HARRIS ASSOCIATES INVESTMENT TRUST | 1,987,902 | 0 | 0 | 0 | For |
| Charles Schwab | 1,734,521 | 0 | 0 | 0 | For |
| MFS | 1,568,797 | 0 | 0 | 0 | For |
| TIAA | 1,383,393 | 0 | 0 | 0 | For |
| Capital Group | 1,057,832 | 0 | 0 | 0 | For |
| John Hancock | 959,122 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 924,953 | 0 | 0 | 0 | For |
| Hartford | 812,358 | 194 | 0 | 0 | For |
| Dimensional | 790,471 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL SERIES FUNDS | 700,704 | 0 | 0 | 0 | For |
| First Trust | 597,911 | 0 | 0 | 0 | For |
| GMO | 589,528 | 0 | 0 | 0 | For |
| BNY Mellon | 45,992 | 538,739 | 0 | 0 | Mixed |
| SEQUOIA FUND INC | 532,467 | 0 | 0 | 0 | For |
| Jackson National | 353,563 | 163,237 | 0 | 0 | Mixed |
| Brighthouse | 505,149 | 467 | 0 | 0 | For |
| Nuveen | 440,529 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 341,168 | 0 | 0 | 0 | For |
Showing the 25 largest of 198 asset managers. All 198 are in the interactive database (link above).
Proposed by: Trillium ESG Global Equity Fund
Combines 8 wordings of this item as funds reported it.
9% Not approved · of votes cast
Description as filed by funds: Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax- Exempt Political Groups.
Elevance Health, Inc.’s own tally for this item (“4. Shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups”): 15,587,160 for, 162,924,290 against — failed, per its Form 8-K filed May 13, 2026 (Item 5.07).
Reported outcome: Not approved, in the filing’s own words: “The shareholder proposal requesting a study on the impact of prohibiting corporate contributions to partisan 527 tax-exempt political groups was not approved based upon the following votes:”
Support: 9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Elevance Health, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Oversee and Report on Independent Study Related to Company's Political Contributions” (6 managers, 4,824 for, 299,054 against); “S/H Proposal - Political/Government” (2 managers, 99 for, 9 against).
The 199 asset managers below reported 431,044 for, 63,617,600 against, 104,710 abstained, 169 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 25,309 | 20,005,538 | 14 | 0 | Against |
| BlackRock | 5,293 | 7,235,332 | 0 | 0 | Against |
| Fidelity | 0 | 5,246,575 | 0 | 0 | Against |
| FIRST EAGLE FUNDS | 0 | 3,019,702 | 0 | 0 | Against |
| Invesco | 0 | 2,644,440 | 0 | 0 | Against |
| State Street | 591 | 2,450,177 | 0 | 0 | Against |
| T. Rowe Price | 0 | 2,029,476 | 0 | 0 | Against |
| HARRIS ASSOCIATES INVESTMENT TRUST | 0 | 1,987,902 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,734,521 | 0 | 0 | Against |
| MFS | 0 | 1,568,797 | 0 | 0 | Against |
| TIAA | 0 | 1,383,393 | 0 | 0 | Against |
| Capital Group | 0 | 1,057,832 | 0 | 0 | Against |
| John Hancock | 0 | 959,122 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 924,953 | 0 | 0 | Against |
| Hartford | 0 | 812,552 | 0 | 0 | Against |
| Dimensional | 0 | 790,471 | 0 | 0 | Against |
| FRANKLIN MUTUAL SERIES FUNDS | 0 | 700,704 | 0 | 0 | Against |
| First Trust | 0 | 597,911 | 0 | 0 | Against |
| GMO | 0 | 589,528 | 0 | 0 | Against |
| BNY Mellon | 0 | 584,731 | 0 | 0 | Against |
| SEQUOIA FUND INC | 0 | 532,467 | 0 | 0 | Against |
| Jackson National | 0 | 516,800 | 0 | 0 | Against |
| Nuveen | 0 | 440,529 | 0 | 0 | Against |
| Brighthouse | 0 | 418,354 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 0 | 341,168 | 0 | 0 | Against |
Showing the 25 largest of 199 asset managers. All 199 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of May 14, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 217,162,380 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.22% |
| 2 | BlackRock | 3.33% |
| 3 | Fidelity | 2.42% |
| 4 | FIRST EAGLE FUNDS | 1.39% |
| 5 | Invesco | 1.22% |
| 6 | State Street | 1.13% |
| 7 | T. Rowe Price | 0.93% |
| 8 | HARRIS ASSOCIATES INVESTMENT TRUST | 0.92% |
| 9 | Charles Schwab | 0.80% |
| 10 | MFS | 0.72% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 4.55% |
| 2 | Wellington | 3.59% |
| 3 | State Street | 3.03% |
| 4 | T. Rowe Price | 2.45% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.40% |
| 6 | Invesco | 2.08% |
| 7 | HARRIS ASSOCIATES L P | 2.00% |
| 8 | Artisan | 1.94% |
| 9 | First Eagle Investment Management, LLC | 1.73% |
| 10 | Sanders Capital, LLC | 1.43% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 19,887,111 | 9.16% | Form 13F, quarter ended March 31, 2026 |
| State Street | 10,288,696 | 4.74% | Form 13F, quarter ended March 31, 2026 |
| Wellington Management | 8,228,537 | 3.79% | Form 13F, quarter ended March 31, 2026 |
| Invesco | 4,817,410 | 2.22% | Form 13F, quarter ended March 31, 2026 |
| T. Rowe Price | 4,746,585 | 2.19% | Form 13F, quarter ended March 31, 2026 |
| BNY Mellon | 2,845,280 | 1.31% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 2,521,123 | 1.16% | Form 13F, quarter ended March 31, 2026 |
| Northern Trust | 2,158,025 | 0.99% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 217,162,380 shares outstanding, as reported by Elevance Health, Inc. on its Form 10-Q dated April 15, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Elevance Health, Inc.'s shareholder meeting held May 13, 2026, in the 2025-2026 proxy season, 1,158 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 7,403 separate fund positions. On the most widely held item on that ballot — Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay"). — Elevance Health, Inc.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Elevance Health, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 13, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Elevance Health, Inc.’s 10-Q dated April 15, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Elevance Health, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Elevance Health (ELV) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/elevance-health-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.